Table 1 Clinical and socio-demographic characteristics of the study patientsa
From: Prevalence and incidence of multiple sclerosis in central Poland, 2010–2014
Variable | Patients with MS |
|---|---|
(n = 1462) | |
Male, n (%) | 430 (29.4) |
Female, n (%) | 1032 (70.6) |
Age, years, mean ± SD (range) | |
At the prevalence day | 43.3 ± 11.9 (18–78) |
At disease onset | 29.8 ± 8.6 (16–56) |
Initial signs at onset, n (%) | |
Pyramidal | 365 (25.1) |
Sensory | 161 (10.8) |
Visual | 251 (17.2) |
Brainstem | 115 (7.9) |
Cerebellar | 74 (5.1) |
Spinal cord | 65 (4.4) |
Polysymptomatic | 432 (29.5) |
Disease course subtypes, n (%) | |
Relapsing remitting | 997 (68.2) |
Secondary progressive | 317 (21.7) |
Primary progressive | 148 (10.1) |
Treatment during the follow-up period, n (%)b | 341 (23.3) |
Interferon beta | 227 (15.5) |
Glatiramer acetate | 79 (5.4) |
Selective immunosuppressants (natalizumab and fingolimod) | 35 (2.4) |
Educational level, n (%) | |
Higher | 212 (14.5) |
Secondary | 763 (52.2) |
Elementary | 487 (33.3) |